EUVIMEDEUVIMED entdecken
Crossref

Transfusion utilization during gene therapy for sickle cell disease: A single institution experience

Ross M Fasano, Elizabeth M Cappello, Reuben P Jacob iD, Patricia E Zerra, Ann E Haight, Suhag Parikh iD, Elizabeth Stenger, Marianne E M Yee iD

Transfusion · 2026

DOI: 10.1111/trf.70189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2026. Verfasst von Ross M Fasano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia…. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Genetic Therapy, Erythrocyte Transfusion, Blood Transfusion. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gene therapy (GT) is a transformative therapy for sickle cell disease (SCD) that requires transfusion support to suppress hemoglobin S (HbS) for hematopoietic progenitor cell (HPC) mobilization and autologous hematopoietic cell transplantation (HCT). Given the prevalence of red blood cell (RBC) alloimmunization in patients with SCD and recommendations to provide prophylactic minor antigen matching, knowledge of transfusion utilization and duration during the GT process is necessary for transfusion management. Study Design and Methods We performed a retrospective review of transfusion utilization of all patients with SCD who received GT at our center through 2024. Transfusions were recorded for three time periods: (1) ≤120 days before first HPC collection, (2) time from first collection to HPC infusion, (3) HPC infusion to transfusion independence.

Results

Nine patients received GT, 4 (44%) with RBC alloimmunization. One patient became alloimmunized (ant‐Jk a ) during pre‐HPC transfusion management. Four patients had 1 mobilization cycle, 5 patients had 2 cycles, with a median of 3 collection days (1–5). Median RBC transfusion utilization was 38 units (range 27–55): 15 units (9–27) for Period 1, 20 units (10–30) for Period 2, 6 units (4–9) for Period 3. Median platelet utilization was 13 units (7–31) in Period 3.

Discussion

The transfusion support of patients with SCD during GT has unique considerations due to RBC transfusion requirements for HPC mobilization cycles. This single institution report will help support transfusion planning and decision making about the feasibility of transfusion support for patients with extensive RBC alloimmunization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellGenetic TherapyErythrocyte TransfusionBlood TransfusionHumansFemaleRetrospective StudiesMaleAdultHematopoietic Stem Cell TransplantationAdolescentYoung Adult

Autor:innen und Institutionen

  • Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Department of Pathology & Laboratory Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.

ORCID-Profile: Reuben P Jacob, Suhag Parikh, Marianne E M Yee

Zitieren

APA

Fasano, R. M., Cappello, E. M., Jacob, R. P., Zerra, P. E., Haight, A. E., Parikh, S., Stenger, E., & Yee, M. E. M. (2026). Transfusion utilization during gene therapy for sickle cell disease: A single institution experience. Transfusion. https://doi.org/10.1111/trf.70189

Vancouver

Fasano RM, Cappello EM, Jacob RP, Zerra PE, Haight AE, Parikh S, et al. Transfusion utilization during gene therapy for sickle cell disease: A single institution experience. Transfusion. 2026. doi:10.1111/trf.70189

BibTeX
@article{Fasano2026,
  author = {Fasano, Ross M and Cappello, Elizabeth M and Jacob, Reuben P and Zerra, Patricia E and Haight, Ann E and Parikh, Suhag and Stenger, Elizabeth and Yee, Marianne E M},
  title = {Transfusion utilization during gene therapy for sickle cell disease: A single institution experience},
  journal = {Transfusion},
  year = {2026},
  doi = {10.1111/trf.70189}
}
Kostenlos starten →